AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 289: F8-F28, 2005; doi:10.1152/ajprenal.00336.2004
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (158)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dusso, A. S.
Right arrow Articles by Slatopolsky, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dusso, A. S.
Right arrow Articles by Slatopolsky, E.

INVITED REVIEW

Vitamin D

Adriana S. Dusso, Alex J. Brown, and Eduardo Slatopolsky

Renal Division, Washington University School of Medicine, St. Louis, Missouri

The vitamin D endocrine system plays an essential role in calcium homeostasis and bone metabolism, but research during the past two decades has revealed a diverse range of biological actions that include induction of cell differentiation, inhibition of cell growth, immunomodulation, and control of other hormonal systems. Vitamin D itself is a prohormone that is metabolically converted to the active metabolite, 1,25-dihydroxyvitamin D [1,25(OH)2D]. This vitamin D hormone activates its cellular receptor (vitamin D receptor or VDR), which alters the transcription rates of target genes responsible for the biological responses. This review focuses on several recent developments that extend our understanding of the complexities of vitamin D metabolism and actions: the final step in the activation of vitamin D, conversion of 25-hydroxyvitamin D to 1,25(OH)2D in renal proximal tubules, is now known to involve facilitated uptake and intracellular delivery of the precursor to 1{alpha}-hydroxylase. Emerging evidence using mice lacking the VDR and/or 1{alpha}-hydroxylase indicates both 1,25(OH)2D3-dependent and -independent actions of the VDR as well as VDR-dependent and -independent actions of 1,25(OH)2D3. Thus the vitamin D system may involve more than a single receptor and ligand. The presence of 1{alpha}-hydroxylase in many target cells indicates autocrine/paracrine functions for 1,25(OH)2D3 in the control of cell proliferation and differentiation. This local production of 1,25(OH)2D3 is dependent on circulating precursor levels, providing a potential explanation for the association of vitamin D deficiency with various cancers and autoimmune diseases.

vitamin D metabolism; vitamin D receptor; calcium homeostasis; transcriptional regulation; rapid steroid actions


Address for reprint requests and other correspondence: E. Slatopolsky, Dept. of Internal Medicine, Washington University School of Medicine, Campus Box 8126, 660 S. Euclid Ave., St. Louis, MO 63110-1093 (E-mail: eslatopo{at}im.wustl.edu)




This article has been cited by other articles:


Home page
 CJASNHome page
D. V. Barreto, F. C. Barreto, S. Liabeuf, M. Temmar, F. Boitte, G. Choukroun, A. Fournier, and Z. A. Massy
Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1128 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Zittermann, S. S. Schleithoff, S. Frisch, C. Gotting, J. Kuhn, H. Koertke, K. Kleesiek, G. Tenderich, and R. Koerfer
Circulating Calcitriol Concentrations and Total Mortality
Clin. Chem., June 1, 2009; 55(6): 1163 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Okamura, Y. Takano, Y. Saito, J. Yao, and M. Kitamura
Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor
Nephrol. Dial. Transplant., May 27, 2009; (2009) gfp243v1.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Wong, F. L. Szeto, W. Zhang, H. Ye, J. Kong, Z. Zhang, X. J. Sun, and Y. C. Li
Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E820 - E828.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Matsui, T. Hamano, K. Tomida, K. Inoue, Y. Takabatake, Y. Nagasawa, N. Kawada, T. Ito, H. Kawachi, H. Rakugi, et al.
Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats
Nephrol. Dial. Transplant., March 18, 2009; (2009) gfp117v1.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Tentori, J. M. Albert, E. W. Young, M. J. Blayney, B. M. Robinson, R. L. Pisoni, T. Akiba, R. N. Greenwood, N. Kimata, N. W. Levin, et al.
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 963 - 972.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
P. Evenepoel, B. Van Den Bergh, M. Naesens, H. De Jonge, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem
Calcium Metabolism in the Early Posttransplantation Period
Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 665 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 611 - 618.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. N Artaza and K. C Norris
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells
J. Endocrinol., February 1, 2009; 200(2): 207 - 221.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. E. Christensen, P. H Nissen, P. Vestergaard, L. Heickendorff, L. Rejnmark, K. Brixen, and L. Mosekilde
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism
Eur. J. Endocrinol., December 1, 2008; 159(6): 719 - 727.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. Chen, D. J. Glenn, W. Ni, C. L. Grigsby, K. Olsen, M. Nishimoto, C. S. Law, and D. G. Gardner
Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart
Hypertension, December 1, 2008; 52(6): 1106 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb
Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3554 - 3565.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Jean, J.-C. Terrat, T. Vanel, J.-M. Hurot, C. Lorriaux, B. Mayor, and C. Chazot
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3670 - 3676.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
H. J. Lee, S. Paul, N. Atalla, P. E. Thomas, X. Lin, I. Yang, B. Buckley, G. Lu, X. Zheng, Y.-R. Lou, et al.
Gemini Vitamin D Analogues Inhibit Estrogen Receptor-Positive and Estrogen Receptor-Negative Mammary Tumorigenesis without Hypercalcemic Toxicity
Cancer Prevention Research, November 1, 2008; 1(6): 476 - 484.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. Leventis and S. Patel
Clinical aspects of vitamin D in the management of rheumatoid arthritis
Rheumatology, November 1, 2008; 47(11): 1617 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
W. Al-Badr and K. J. Martin
Vitamin D and Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1555 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. Dobnig, S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, B. Wellnitz, J. Kinkeldei, B. O. Boehm, G. Weihrauch, and W. Maerz
Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality
Arch Intern Med, June 23, 2008; 168(12): 1340 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
K. Olgaard and E. Lewin
Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1786 - 1789.
[Full Text] [PDF]

Home page
 Poult. Sci.Home page
D. Praslickova, S. Sharif, A. Sarson, M. F. Abdul-Careem, D. Zadworny, A. Kulenkamp, G. Ansah, and U. Kuhnlein
Association of a Marker in the Vitamin D Receptor Gene with Marek's Disease Resistance in Poultry
Poult. Sci., June 1, 2008; 87(6): 1112 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Shroff, M. Egerton, M. Bridel, V. Shah, A. E. Donald, T. J. Cole, M. P. Hiorns, J. E. Deanfield, and L. Rees
A Bimodal Association of Vitamin D Levels and Vascular Disease in Children on Dialysis
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1239 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
C. Lomonte, L. Vernaglione, D. Chimienti, A. Bruno, S. Cocola, A. Teutonico, F. Cazzato, and C. Basile
Does Vitamin D Receptor and Calcium Receptor Activation Therapy Play a Role in the Histopathologic Alterations of Parathyroid Glands in Refractory Uremic Hyperparathyroidism?
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 794 - 799.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
D. A. Bushinsky and P. Messa
Efficacy of Early Treatment with Calcimimetics in Combination with Reduced Doses of Vitamin D Sterols in Dialysis Patients
NDT Plus, January 1, 2008; 1(suppl_1): i18 - i23.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
A. L. M. de Francisco and F. Carrera
A New Paradigm for the Treatment of Secondary Hyperparathyroidism
NDT Plus, January 1, 2008; 1(suppl_1): i24 - i28.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. J. Lee, Y. Ji, S. Paul, H. Maehr, M. Uskokovic, and N. Suh
Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D3 Analogue Is Mediated by Ras/Protein Kinase C{alpha}
Cancer Res., December 15, 2007; 67(24): 11840 - 11847.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
T. E. Willnow, A. Hammes, and S. Eaton
Lipoproteins and their receptors in embryonic development: more than cholesterol clearance
Development, September 15, 2007; 134(18): 3239 - 3249.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. F. Holick
Vitamin D Deficiency
N. Engl. J. Med., July 19, 2007; 357(3): 266 - 281.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Drueke, D. Martin, and M. Rodriguez
Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Mizobuchi, J. Morrissey, J. L. Finch, D. R. Martin, H. Liapis, T. Akizawa, and E. Slatopolsky
Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1796 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 cfpHome page
G. Schwalfenberg
Not enough vitamin D: Health consequences for Canadians
Can Fam Physician, May 1, 2007; 53(5): 841 - 854.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. M. Albert, E. A. Scheef, S. Wang, F. Mehraein, S. R. Darjatmoko, C. M. Sorenson, and N. Sheibani
Calcitriol Is a Potent Inhibitor of Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2327 - 2334.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. Takano, K. Yamauchi, N. Hiramatsu, A. Kasai, K. Hayakawa, M. Yokouchi, J. Yao, and M. Kitamura
Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1573 - F1582.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
Y. Bosse, K. Maghni, and T. J. Hudson
1{alpha},25-Dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes
Physiol Genomics, April 24, 2007; 29(2): 161 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
E. T. Chang, V. S. Lee, A. J. Canchola, C. A. Clarke, D. M. Purdie, P. Reynolds, H. Anton-Culver, L. Bernstein, D. Deapen, D. Peel, et al.
Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort
Am. J. Epidemiol., April 1, 2007; 165(7): 802 - 813.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Tian, Y. Liu, L. A. Williams, and D. de Zeeuw
Potential role of active vitamin D in retarding the progression of chronic kidney disease
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 321 - 328.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
E. T. Chang, K. M. Balter, A. Torrang, K. E. Smedby, M. Melbye, C. Sundstrom, B. Glimelius, and H.-O. Adami
Nutrient Intake and Risk of Non-Hodgkin's Lymphoma
Am. J. Epidemiol., December 15, 2006; 164(12): 1222 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
X. Tan, Y. Li, and Y. Liu
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3382 - 3393.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M Lammert, J M Friedman, H J Roth, R E Friedrich, L Kluwe, D Atkins, T Schooler, and V-F Mautner
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
J. Med. Genet., October 1, 2006; 43(10): 810 - 813.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
R.M. Francis, F.H. Anderson, S. Patel, O. Sahota, and T.P. van Staa
Calcium and vitamin D in the prevention of osteoporotic fractures
QJM, June 1, 2006; 99(6): 355 - 363.
[Full Text] [PDF]

Home page
 Int J EpidemiolHome page
K. M Egan
Commentary: Sunlight, vitamin D, and the cancer connection revisited
Int. J. Epidemiol., April 1, 2006; 35(2): 227 - 230.
[Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
A. K. Singh, R. Chauhan, and P. Kushwah
Haste in Starting Therapy for Depression
J Am Board Fam Med, September 1, 2005; 18(5): 445 - 445.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.